1. Home
  2. MDAIW vs PVBC Comparison

MDAIW vs PVBC Comparison

Compare MDAIW & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • PVBC
  • Stock Information
  • Founded
  • MDAIW N/A
  • PVBC 1913
  • Country
  • MDAIW United States
  • PVBC United States
  • Employees
  • MDAIW 78
  • PVBC N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • PVBC Major Banks
  • Sector
  • MDAIW Health Care
  • PVBC Finance
  • Exchange
  • MDAIW Nasdaq
  • PVBC Nasdaq
  • Market Cap
  • MDAIW N/A
  • PVBC N/A
  • IPO Year
  • MDAIW N/A
  • PVBC 2015
  • Fundamental
  • Price
  • MDAIW $0.29
  • PVBC $11.24
  • Analyst Decision
  • MDAIW
  • PVBC Hold
  • Analyst Count
  • MDAIW 0
  • PVBC 1
  • Target Price
  • MDAIW N/A
  • PVBC $12.50
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • PVBC 23.3K
  • Earning Date
  • MDAIW 02-27-2025
  • PVBC 04-25-2025
  • Dividend Yield
  • MDAIW N/A
  • PVBC N/A
  • EPS Growth
  • MDAIW N/A
  • PVBC N/A
  • EPS
  • MDAIW N/A
  • PVBC 0.26
  • Revenue
  • MDAIW $27,264,000.00
  • PVBC $50,244,000.00
  • Revenue This Year
  • MDAIW N/A
  • PVBC $12.13
  • Revenue Next Year
  • MDAIW N/A
  • PVBC $4.76
  • P/E Ratio
  • MDAIW N/A
  • PVBC $42.92
  • Revenue Growth
  • MDAIW 44.52
  • PVBC N/A
  • 52 Week Low
  • MDAIW $0.08
  • PVBC $9.09
  • 52 Week High
  • MDAIW $0.90
  • PVBC $12.96
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • PVBC 51.69
  • Support Level
  • MDAIW N/A
  • PVBC $10.97
  • Resistance Level
  • MDAIW N/A
  • PVBC $11.28
  • Average True Range (ATR)
  • MDAIW 0.00
  • PVBC 0.25
  • MACD
  • MDAIW 0.00
  • PVBC 0.04
  • Stochastic Oscillator
  • MDAIW 0.00
  • PVBC 50.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: